Jeffrey Paley's Net Worth
$1.12 Million
Who is Jeffrey Paley?
Jeffrey Paley has an estimated net worth of $1.12 Million. This is based on reported shares across multiple companies, which include Retrophin, Inc., AVENUE THERAPEUTICS, INC., Journey Medical Corp, and IMMUNE PHARMACEUTICALS INC.
SEC CIK
Jeffrey Paley's CIK is 0001595327
Past Insider Trading and Trends
2016 was Jeffrey Paley's most active year for acquiring shares with 3 total transactions. Jeffrey Paley's most active month to acquire stocks was the month of November. 2023 was Jeffrey Paley's most active year for disposing of shares, totalling 3 transactions. Jeffrey Paley's most active month to dispose stocks was the month of October. 2023 saw Jeffrey Paley paying a total of $133,800.00 for 72,472 shares, this is the most they've acquired in one year. In 2014 Jeffrey Paley cashed out on 20,000 shares for a total of $245,598.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Retrophin, Inc. (TVTX) Snapshot price: $8.295
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -27.91% | -20.00K |
$12.28 | -$245,598.00 | 51.66K |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
| No matching records found | |||||||||
AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $0.1223
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.20% | 15K |
$5.24 | $78,554.00 | 79.66K |
Dec 3 - Dec 10
| |||
Form 4
| +29.33% | 14.66K |
—
|
—
| 64.66K |
Aug 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.14% | -2.50K |
$3.51 | -$8,771.40 | 114.22K |
Nov 7 - Nov 8
| |||
Form 4
| -2.41% | -1.75K |
$5.22 | -$9,108.90 | 70.73K |
Nov 28
| |||
Form 4
| +26.10% | 15K |
$2.98 | $44,700.00 | 72.47K |
Oct 6
| |||
Form 4
| +109.20% | 30K |
$2.97 | $89,100.00 | 57.47K |
Sep 21
| |||
Form 4
| +62.09% | 27.47K |
—
|
—
| 71.72K |
Jul 21
| |||
Form 4
| +47.48% | 14.24K |
—
|
—
| 44.24K |
Jul 21
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||